Morgan Stanley Lowers United Health Price Target to $325, Maintains Overweight

UnitedHealth Group Incorporated (NYSE:UNH) is one of the stocks on Jim Cramer’s and analysts’ radar. On August 20, Morgan Stanley reduced its price target on UNH shares to $325 from $342 and maintained an Overweight rating. The firm revised its estimates to reflect a longer turnaround timeline. It noted that its illustrative path to 2027 EPS suggests potential upside to current Street expectations, while highlighting uncertainties related to Medicare Star ratings and possible changes in regulation and reimbursement.

Morgan Stanley Lowers United Health Price Target to $325, Maintains Overweight

Ken Wolter/Shutterstock.com

UnitedHealth Group Incorporated (NYSE:UNH) provides health benefits, care services, pharmacy programs, and data solutions to a wide range of customers, including individuals, employers, healthcare providers, and government entities. The company offers health coverage, care delivery, consulting, software, and pharmacy management services. It should be noted that Cramer, on August 13, mentioned that the company can make a comeback. He stated:

“I think UnitedHealth’s going to work here… I think it’s going to work. I really do. Look, I’m not a believer. I don’t like the fact that they had shenanigans, but I will say this: I think that the company is run by a very good CEO. It could come back.”

While we acknowledge the risk and potential of UNH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than UNH and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.